参考文献/References:
[1] 王彦鹏,全健,郝龙飞,等.接骨丹联合经皮椎体后凸成形术治疗老年骨质疏松性椎体压缩骨折疗效研究[J].陕西中医,2023,44(7):901-904.
[2] PAN B,CAI J,ZHAO P,et al.Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease:A systematic review and meta-analysis[J].Osteoporos Int,2022,33(11):2275-2286.
[3] 张恒林,吴克弟,王声威,等.CIRCRNA_0001795及CIRCRNA_0048211在老年骨质疏松症中的表达[J].中国骨质疏松杂志,2023,29(2):189-194.
[4] 符桑,文章新,陈蓉,等.跟骨定量超声在中老年2型糖尿病并发骨质疏松症预测诊断中的应用[J].中华骨质疏松和骨矿盐疾病杂志,2021,14(4):352-359.
[5] COLAK Y,AFZAL S,NORDESTGAARD B G.25-hydroxyvitamin d and risk of osteoporotic fractures:Mendelian randomization analysis in 2 large population-based cohorts[J].Clin Chem,2020,66(5):676-685.
[6] 王荣锋,郁昊,蒋新建.老年糖尿病患者血清25羟维生素D水平与骨质疏松相关性研究[J].陕西医学杂志,2019,48(8):1032-1034,1041.
[7] WANG S,SUN W,ZHOU X.Bone metabolism discrepancy in type 2 diabetes mellitus patients with and without non-alcoholic fatty liver disease[J].J Clin Densitom,2022,25(4):553-558.
[8] WEN Y,LI H,ZHANG X,et al.Correlation of osteoporosis in patients with newly diagnosed type 2 diabetes:A retrospective study in chinese population[J].Front Endocrinol(Lausanne),2021,14(12):531-540.
[9] 邱贵兴,裴福兴,胡侦明,等.中国骨质疏松性骨折诊疗指南(骨质疏松性骨折诊断及治疗原则)[J].中华骨与关节外科杂志,2015,8(5):371-374.
[10] 岳建彪,苟静,魏翾娣,等.中医综合疗法联合运动干预治疗老年绝经后骨质疏松症临床研究[J].陕西中医,2022,43(10):1380-1383.
[11] JI S,JIANG X,HAN H,et al.Prediabetes and osteoporotic fracture risk:A meta-analysis of prospective cohort studies[J].Diabetes Metab Res Rev,2022,38(7):e3568.
[12] 王猛,党星波,周永春,等.地舒单抗治疗老年性骨质疏松疗效及对患者骨密度、骨代谢的影响[J].陕西医学杂志,2023,52(10):1395-1398.
[13] 朱峰,陈东,刘畅,等.特立帕肽治疗甲状旁腺全切术后低全段甲状旁腺激素患者的疗效观察[J].上海医学,2021,44(12):897-901.
[14] 吴曼,仇莉,文燕,等.中老年骨质疏松与β胶原特殊序列和总1型胶原氨基端延长肽比值的相关性[J].中国临床保健杂志,2023,26(4):508-510.
[15] 相爱霞,宋勇刚,吕淑云,等.2型糖尿病患者糖化血红蛋白变异指数与骨代谢标志物的相关性研究[J].中华糖尿病杂志,2022,14(10):1080-1084.
[16] ZHANG H,HU Y,CHEN X,et al.Expert consensus on the bone repair strategy for osteoporotic fractures in China[J].Front Endocrinol(Lausanne),2022,13:989648.
[17] 方圣杰,李秋月,刘宁,等.基于RUNX2、VEGF蛋白研究补骨生髓方治疗老年性骨质疏松症的作用机制[J].中国中医基础医学杂志,2023,29(4):561-565.
[18] 王有秀,冯彩滑,蔡成英,等.老年2型糖尿病病人炎症因子及25羟维生素D水平与骨质疏松症的关系研究[J].实用老年医学,2020,34(2):133-136.
[19] 张建华,但刚,胡莉娜,等.血清OC、25(OH)D及PTH水平与老年骨质疏松患者胸腰椎骨折的关系及其预测价值分析[J].现代生物医学进展,2023,23(18):3499-3503.
[20] 徐文,邹明,岳建彪.血清高T-PINP/β-CTX比值和正常低TSH水平与老年女性骨质疏松性椎体骨折相关性研究[J].中国骨质疏松杂志,2022,28(2):162-167.
[21] ZHAO S,MO X,WEN Z,et al.Declining serum bone turnover markers are associated with the short-term positive change of lumbar spine bone mineral density in postmenopausal women[J].Menopause,2022,29(3):335-343.
[22] 徐艺筝,邹明,岳建彪,等.血清TSH和T-PINP/β-CTX比值对老年椎体骨折患者的诊断价值[J].中国骨质疏松杂志,2021,27(5):673-677.
[23] 查显友,周燕,费玉娥.骨代谢标志物在老年痴呆患者骨质疏松症早期诊断中的临床价值[J].中国卫生检验杂志,2022,32(13):1582-1585.
[24] 吴林清,陈运崇,张国如,等.血清SM4D水平与绝经后骨质疏松症患者骨密度和骨代谢指标的相关性研究[J].中国骨质疏松杂志,2021,27(3):392-395.
[25] LAWLER T,WARREN ANDERSEN S.Serum 25-hydroxyvitamin D and cancer risk:A systematic review of mendelian randomization studies[J].Nutrients,2023,15(2):422.
[26] 王欣燕,刘建红,黄显元.青娥丸对绝经后骨质疏松症患者骨密度、骨代谢指标和骨硬化蛋白的影响[J].中国骨质疏松杂志,2020,26(3):412-415.
[27] STEWART C C,OHARA N N,ORWIG D,et al.Serum 25(OH)D is associated with an altered bone turnover marker response after a hip fracture[J].Journal of Orthopaedic Research,2019,37(3):535-540.